AIDS-related Kaposi sarcoma, version 2.2019

Erin Reid, Gita Suneja, Richard F. Ambinder, Kevin Ard, Robert Baiocchi, Stefan K. Barta, Evie Carchman, Adam Cohen, Oxana V. Crysler, Neel Gupta, Chelsea Gustafson, Allison Hall, Kimberly L. Johung, Ann Klopp, Ann S. LaCasce, Chi Lin, Amitkumar Mehta, Manoj P. Menon, David Morgan, Nitya NathwaniAriela Noy, Lee Ratner, Stacey Rizza, Michelle A. Rudek, Julian Sanchez, Jeff Taylor, Benjamin Tomlinson, Chia Ching J. Wang, Sai Yendamuri, Mary A. Dwyer, Deborah A. Freedman-Cass

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.

Original languageEnglish (US)
Pages (from-to)171-189
Number of pages19
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume17
Issue number2
DOIs
StatePublished - Feb 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'AIDS-related Kaposi sarcoma, version 2.2019'. Together they form a unique fingerprint.

Cite this